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Abstract
Human metapneumovirus (hMPV) is a respiratory viral pathogen in children worldwide. hMPV is divided into four subtypes:
hMPV_A1, hMPV_A2, hMPV_B1, and hMPV_B2. hMPV_A2 can be further divided into hMPV_A2a and A2b based on
phylogenetic analysis. The typical prevalence pattern of hMPV involves a shift of the predominant subtype within one or
two years. However, hMPV_A2, in particular hMPV_A2b, has circulated worldwide with a several years long term high
epidemic. To study this distinct epidemic behavior of hMPV_A2, we analyzed 294 sequences of partial G genes of the virus
from different countries. Molecular evolutionary data indicates that hMPV_A2 evolved toward heterogeneity faster than the
other subtypes. Specifically, a Bayesian skyline plot analysis revealed that hMPV_A2 has undergone a generally upward
fluctuation since 1997, whereas the other subtypes experienced only one upward fluctuation. Although hMPV_A2 showed a
lower value of mean dN/dS than the other subtypes, it had the largest number of positive selection sites. Meanwhile,
various styles of mutation were observed in the mutation hotspots of hMPV_A2b. Bayesian phylogeography analysis also
revealed two fusions of diffusion routes of hMPV_A2b in India (June 2006) and Beijing, China (June 2008). Sequences of
hMPV_A2b retrieved from GenBank boosted simultaneously with the two fusions respectively, indicating that fusion of
genetic transmission routes from different regions improved survival of hMPV_A2. Epidemic and evolutionary dynamics of
hMPV_A2b were similar to those of hMPV_A2. Overall, our findings provide important molecular insights into hMPV
epidemics and viral variation, and explain the occurrence of an atypical epidemic of hMPV_A2, particularly hMPV_A2b.
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Introduction
Human metapneumovirus (hMPV), first identified in 2001 in
the Netherlands, is an enveloped, non-segmented, RNA virus that
belongs to the Paramyxoviridae family and pneumovirus subfamily [1].
It is an important respiratory viral pathogen in children, which
circulates in all age groups worldwide, causing illnesses that range
from mild colds to severe lower respiratory tract diseases [1–3].
The genome of hMPV is approximately 13 kb in length and is
comprised of eight genes, encoding nucleocapsid (N), phospho-
protein (P), matrix protein (M), fusion glycoprotein (F), transcrip-
tional enhancer protein (M2-1), small hydrophobic protein (SH),
attachment glycoprotein (G), and a large polymerase protein (L)
[4]. As a type II membrane protein, the hMPV G protein plays an
important role in viral attachment and is a potential target for
neutralizing and protective immune responses [5,6]. Accordingly,
the G protein shows extensive amino acid variations, mostly in the
ectodomain, that help the virus to escape immunity pressure from
hosts [7,8]. Thus, the G protein has been widely used to infer
evolutionary relationships among isolates from different regions
[8–10]. Based on genetic variability of the G gene, hMPV has
been divided into two genotypes (A and B) and four subtypes (A1,
A2, B1, and B2) [8,11]. There are two subgroups of hMPV_A2,
hMPV_A2a and hMPV_A2b, the latter of which was identified in
Germany in 2006 [12].
The prevalence pattern of hMPV is similar to that of respiratory
syncytial virus; two subgroups of the virus can co-circulate with
varying degrees of prevalence [13,14]. Shifts in the predominant
hMPV subtype within one or two years are typical in the
prevalence pattern of hMPV, and can be attributed to the
response to the existing immunity against circulating strains [11–
12,15–19]. However, such a shift has not been observed in the
prevalence pattern of the hMPV_A2 subtype. Reports from
Korea, Mexico, Italy, and Germany indicate that hMPV_A2 can
maintain predominance for three or more years, rather than
undergoing the shift observed in other hMPV subtypes [15,20–
23]. The mechanism behind this distinctive epidemic feature of
hMPV_A2 is unclear.
Here, we compiled the epidemic patterns of the hMPV subtypes
based on the global incidences of hMPV subtypes, using published
data as well as our own data collected between 1999 and 2009. We
found that hMPV_A2 was predominant from 2002 to 2009. To
PLoS ONE | www.plosone.org 1 March 2012 | Volume 7 | Issue 3 | e34544interpret the mechanisms behind this phenomenon, we recon-
structed and compared the evolutionary dynamics of all hMPV
subtypes, particularly the phylodynamics of hMPV_A2a and A2b,
based on sequences of the G gene. Our findings provide insights
into the prevalence pattern of the hMPV subtypes and the
evolutionary mechanism behind the atypical prevalence pattern of
hMPV_A2.
Materials and Methods
Sample collection
A total of 60 hMPV-positive respiratory specimens were taken
from pediatric and adult patients with acute respiratory tract
infections (ARTIs) at the Beijing Children Hospital and the Peking
Union Medical College Hospital in Beijing, China between 2006
and 2009. Sampling was performed once for each patient. The
inclusion criteria of ARTI patients have been described previously
[24,25]. Briefly, the enrolled patients had acute respiratory
symptoms, acute fever (body temperature §38.0uC), and normal
or low leukocyte count. For each adult patient, a nasal and a
throat swab were collected simultaneously. The two swabs were
combined in one tube containing 3 ml viral transport medium
(VTM). For each pediatric patient, about 3 ml of nasopharyngeal
aspirate (NPA) was collected under aseptic conditions. All samples
were stored at 280uC prior to analysis. Clinical information of
each enrolled patient was recorded in a standard form and
reviewed retrospectively upon identification of hMPV-positive
patients. Written informed consent was obtained from all
participants or guardians on behalf of the minors/children
participants. The study was approved by the Medical Ethic
Review Board of the Institute of Pathogen Biology, Chinese
Academy of Medical Sciences. All samples were coded prior to
analysis to ensure anonymity.
Nucleotide amplification and sequencing of hMPV partial
G genes
RNA was extracted from the samples using QIAamp viral RNA
mini Kit (Qiagen, Duesseldorf, Germany), and reverse transcribed
using SuperScript II reverse transcription system (Invitrogen,
Carlsbad, CA) following the manufacturer’s instructions. The
cDNA of hMPV was amplified by nested PCR. The 20 ml PCR
reaction mixture contained 2 ml of reaction mix, 0.4 ml of dNTP
(10 mM), 0.2 ml of each primer (50 mM) and 0.2 ml of Taq
Polymerase. Primers for hMPV genotype A were: outer sense 42-
CAAAGCAAGAGTGAAAAATCGTGTG9, inner sense 44-
AAGCAAGAGTGAAAAATCGTGTGGC, outer antisense
681- TGTTTTTACAATGTTGGTGTGCTAT, and inner anti-
sense 527- GTGGTGGCTCTGGGGACCGCCTTCG. Primers
for hMPV genotype B were: outer/inner sense 104-TTATTG-
GACTAACAGCGTTAAGCAT, outer antisense 805-
ATGGTGTCTATGTTTTTCTGGGTCT, inner antisense
736- TTTTTGTTAACTACTTGGATGGGAT. Two microli-
ters of cDNA was used as template in the first reaction, and 2 mlo f
the first round product was used as template in the second
reaction. The two-round nested PCR was performed using these
cycling conditions: pre-denaturing at 94uC for 180 s; 30 cycles of
amplification at 94uC for 30 s; 50uC for 30 s; and 72uC for 60 s,
with a terminal elongation step at 72uC for 10 min. The sequence
data obtained for the hMPV G gene was deposited to GenBank
under accession numbers JN166985 to JN167044 (Table S1).
hMPV sequence collection and phylogenetic analysis
A total of 234 partial G gene cDNA sequences (www.ncbi.nlm.
nih.gov), derived from samples with known background informa-
tion including collection dates (between 1981 and 2009) and
collection places, were obtained from GenBank. Those sequences
plus the 60 sequences obtained in this study were subjected to
phylogenetic analysis. These 294 sequences represent hMPV
strains from 12 countries and cover most encoding sequences of
the G protein’s ectodomain. To avoid possible sampling bias, all
the sequences used in this study were obtained from simultaneous
screening of all four hMPV subtypes. The background information
of the G gene sequences enrolled in this study is provided in Table
S1.
Estimates of genetic distance were used to evaluate genetic
divergence between hMPV subtypes [26]. The overall mean
distances of the hMPV subtypes were estimated using MEGA
(version 4.0) [27]. A kimura-2 parameter model, gamma-
distributed among-site rate variation with four rate categories
(c4), and 1000 bootstraps were applied for distance estimation.
Phylogenetic reconstructions of the hMPV subtypes were
performed by maximum-likelihood (ML) and neighbor-joining
Figure 1. Global frequencies of hMPV subtypes and hMPV_A2 sublineages between 1999 and 2009. The numbers of global hMPV
infection were compiled from published reports of hMPV prevalence by PubMed index (www.ncbi.nlm.nih.gov/pubmed). Only reports that screened
all four subtypes of hMPV simultaneously were used. The numbers on Y-axis are yearly total qualified sequences of hMPV.
doi:10.1371/journal.pone.0034544.g001
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ny* and other methods, version 4b10 beta) [28], and by the
Bayesian Markov Chain Monte Carlo (MCMC) method using
BEAST (Bayesian evolutionary analysis by sampling trees version
1.5.4) [29]. The best fit nucleotide substitution model (s) for ML
and the Bayesian MCMC analysis were selected using Modeltest
(version 3.7) [30].
Bayesian MCMC evolutionary analysis
Evolutionary parameters, including molecular clock phyloge-
nies, demographic histories, evolution rates, and divergence times,
were jointly estimated from heterochronous G genes of hMPV
subtypes and hMPV_A2 sublineages using the Bayesian MCMC
method implemented in BEAST (version 1.5.4). Bayesian MCMC
analysis was performed using the uncorrelated lognormal-
distributed model (UCLD). Analysis was performed using the best
fit nucleotide substitution model general time reversible (GTR)
with a gamma-distributed among-site rate variation with four rate
categories (c4) as estimated by Modeltest. To determine the degree
to which dating estimates were affected by the demographic tree
model, chosen Bayesian MCMC analyses were repeated using the
constant size and exponential growth tree models. Each Bayesian
MCMC analysis was run for 200 million states and sampled every
5,000 states. Posterior probabilities were calculated using Tracer
(version 1.5) with a burn-in of 2 million states. Bayesian skyline
plots for hMPV_A2a and A2b were estimated to depict the relative
viral genetic diversity (g) over time.
Natural selection and adaptation analysis
Selection pressures on the hMPV G genes were estimated from
the ratios of nonsynonymous to synonymous substitution (dN/dS)
using the codon-based phylogenetic method in CODEML
(distributed in PAML, version 4) [31]. The M2a codon
substitution model of CODEML can estimate three classes of
sites: purifying (0#v,1), neutral (v=1), and positive selection
(v.1) sites. Posterior probabilities of the inferred positive selection
sites were calculated using the Bayes empirical Bayes (BEB)
approach which accounts for sampling errors. Only the sites with a
posterior probability of v.95% were considered as positive
selection sites. Because most viral amino acids are encoded by
more than one codon, a larger value of dN/dS does not always
mean that the chance of an amino acid switch to any given
position is higher. To infer the positive selection sites at the amino
acid level, the deduced amino acid sequence entropy was
determined using BioEdit (version 7.0.9) [32].
To chronologically trace the evolution of nonsynonymous
changes throughout the evolutionary history of hMPV_A2, the
nonsynonymous changes from the heterochronous virus sequences
were reconstructed using a joint maximum likelihood method
using HyPhy software version 0.99 [33]. The occurrence time of
each nonsynonymous substitution in hMPV_A2 was estimated
using the maximum clade credibility (MCC) tree generated from
the Bayesian MCMC molecular clock analysis [29].
Phylogeography analysis
A Bayesian stochastic search variable selection (BSSVS)
approach, included in Beast 1.5.4, that allows the exchange rates
Figure 2. Maximum-likelihood phylogeny of hMPV G genes. A
total of 294 partial G gene sequences of hMPV subtypes and
sublineages with sampling dates between 1999 and 2009 and of
known origin were enrolled. The maximum-likelihood phylogeny was
constructed by PAUP* (version 4b10 beta), using a heuristic of Nearest-
Neighbor-Interchange (NNI) with 100 bootstrap replicates. The tree is
midpoint rooted with a scale bar of 0.1, signifying the genetic distance
of nucleotide substitutions per site. For clarity, the background
information of each sequence is listed in Table S1.
doi:10.1371/journal.pone.0034544.g002
Table 1. Evolutionary characteristics of hMPV subtypes based on G genes.
hMPV sublineages Substitution rate (CR
a) Overall mean distance (S. E.
b)
A1 4.42 (2.20–6.78) 0.040 (0.005)
A2 7.81 (6.20–9.52) 0.112 (0.011)
-A2a 7.36 (4.24–10.59) 0.046 (0.006)
-A2b 7.62 (5.79–9.46) 0.092 (0.010)
B1 8.54 (3.98–13.36) 0.049 (0.006)
B2 4.98 (3.53–6.48) 0.056 (0.005)
All 7.40 (5.72–9.15) 0.459 (0.040)
aSubstitution rates are expressed as 10
23 substitutions per site per year.
bStandard error, derived from 1,000 bootstraps of overall mean distance.
doi:10.1371/journal.pone.0034544.t001
Evolutionary Dynamics of hMPV Subtypes
PLoS ONE | www.plosone.org 3 March 2012 | Volume 7 | Issue 3 | e34544in the CTMC to be zero with some prior probability, was used to
find a minimal set of rates demonstrating the diffusions in the
phylogeny [34]. To identify the rates contributing to the migration
path, a Bayes factor test was performed by comparing the
posterior to prior odds that individual rates are zero. BF.3 was
considered significant.
A maximum clade credibility tree was applied to summarize the
obtained trees using TreeAnnotator which is included in BEAST
1.5.4. To visualize the diffusion rates over time, the location-
annotated MCC tree was converted to a keyhole markup language
(KML), which is suitable for viewing with GoogleEarth (http://
earth.google.com).
Results
Global epidemics of hMPV subtypes
Epidemiological reports on hMPV subtypes during 1999 and
2009 were retrieved from PubMed (www.ncbi.nlm.nih.gov/
pubmed). Only the reports in which all hMPV subtypes were
screened simultaneously were enrolled to avoid sampling bias (see
Table S2 for details). Ten-year epidemic curves of hMPV subtypes
and hMPV_A2 sublineages are summarized in Figure 1. The
epidemic peak of hMPV_A1 occurred in 2002, whereas
hMPV_B1 and _B2 peaked similarly in 2004. As previously
reported, the prevalence of all hMPV subtypes except hMPV_A2
fluctuated every two or three years; the prevalence of hMPV_A2
was atypical as it was long-lasting between 2002 and 2009 with a
drop in 2007. This atypical prevalence of hMPV_A2 can be
attributed mainly to hMPV_A2b, although hMPV_A2a spiked in
2006 (Figure 1).
Phylogenetic relationships of hMPV subtypes
To unveil the factors that were responsible for the atypical
prevalence pattern of hMPV_A2, we first analyzed the phyloge-
netic relationship of each selected hMPV G sequence to confirm
its subtypes. A total of 294 partial G genes corresponding to
nucleotide 6431–6760 qualified (GQ153651); all 294 were derived
from samples collected between 1981 and 2009 and were
subjected to Maximum-likelihood (ML) phylogenetic reconstruc-
tions. The data shows well-supported groups of all subtypes and
hMPV_A2 sublineages (Figure 2). Phylogeographic analysis
revealed a cosmopolitan distribution for the hMPV subtypes and
hMPV_A2 sublineages, and strains from a certain geographical
location gathered within the same cluster. Co-circulation of
multiple subtypes and/or sublineages was observed in some
countries, including China, the Netherlands, South Africa,
Canada, USA and Australia. To verify these findings using the
ML method, the data were analyzed independently using the
Neighbor Joining (NJ) and Parsimony methods. Similar tree
topologies to that by ML method were obtained (data not shown).
The phylogenetic relationship of the hMPV G gene sequences
confirms the subtype division of each selected sequence and
provides a basis for further analysis of evolutionary dynamics.
Evolutionary characteristics of hMPV subtypes
To determine why the atypical pattern of hMPV_A2 prevalence
occurred, we characterized the evolutionary behavior of the
hMPV subtypes. For this purpose, a Bayesian relaxed molecular
clock method was used to estimate the evolutionary characteristics
of hMPV subtypes. The method assumes no a priori correlation
between the evolution rate of a lineage and that of its ancestor.
The evolutionary rates of the G gene were estimated to be 4.42,
7.81, 8.54, and 4.98610
23 substitutions/site/year for hMPV_A1,
A2, B1 and B2, respectively (Table 1). The evolutionary rates of
hMPV_A2 and _B1 were almost two-fold those of hMPV_A1 and
_B2. Estimation of the genetic distance of each hMPV subtype
revealed that hMPV_A2 had the highest overall mean distance of
0.112 (Table 1). These evolutionary characteristics of the hMPV
subtypes suggest that hMPV_A2 evolved toward heterogeneity
faster than the other subtypes.
Dynamics of population growth
To infer the demographic history of hMPV, Bayesian skyline
plots were used to reconstruct the population histories of hMPV
subtypes and hMPV_A2 sublineages from our analysis of the
genetic diversity in the G genes over time. hMPV_A1 showed a
sharp, but transient, increase in relative genetic diversity (g)i n
Figure 3. Genetic diversity dynamics of hMPV subtypes and
hMPV_A2 sublineages. Bayesian skyline plot estimates depicting the
past genetic diversity dynamics of hMPV subtypes (A) and hMPV_A2
sublineages (B) were generated using Bayesian Markov chain Monte
Carlo analysis implemented in Beast 1.5.4. The y axis of the skyline plot
represents genetic diversity (g), which is equal to the product of the
effective population size (Ne) and the generation length in years (t).
Black lines represent the median estimate. Color regions show 95% HPD
limits.
doi:10.1371/journal.pone.0034544.g003
Evolutionary Dynamics of hMPV Subtypes
PLoS ONE | www.plosone.org 4 March 2012 | Volume 7 | Issue 3 | e345442000 followed by an increase in 2001 and then a steep decrease
(Figure 3A). This corresponds to the global increase of hMPV_A1
in 2001 and its decrease in 2002 (Figure 1). The genetic diversity of
hMPV_A2 increased in 1997, 2005, and 2007 (Figure 3A). The
increases in genetic diversity during 2005 and 2007 correspond to
global increases in the epidemic of hMPV_A2. In 1995, hMPV_
B2 exhibited a similar increase in genetic diversity. In 2001, the
genetic diversity and epidemic of hMPV_B1 increased, similar to
the increases seen in hMPV_A2 (Figure 1). As the increase in
genetic diversity of hMPV_B2 occurred before 2001 (the
identifying year of hMPV), no direct relationship was observed
in its epidemic. The history of relative genetic diversity obtained
here largely corresponds to the global epidemic data, demonstrat-
Table 2. Selection analysis of the G genes of hMPV subtypes.
SubtypesMean dN/dS (CI
a) Positive selection site data
Position AA dN/dS ± S.E.
b Entropy
82 A 7.7460.86 1.02
93 Y 7.7460.86 0.45
105 H 7.7460.86 0.67
106 S 7.7460.86 0.72
124 T 7.7460.87 0.43
128 P 7.7260.96 0.67
143 K 7.7460.86 0.45
A1 1.25 (1.23–1.27) 154 P 7.7460.86 0.68
155 R 7.5361.42 0.33
156 T 7.4561.51 0.61
158 S 7.7460.86 0.87
165 R 7.6761.10 0.27
167 T 7.7460.86 0.63
170 T 7.7360.91 0.34
93 H 3.5360.16 0.73
102 P 3.4160.32 0.84
105 N 3.4660.41 0.82
106 P 3.3760.29 0.86
110 V 3.5260.16 0.64
129 S 3.5160.23 0.48
143 K 2.8560.11 0.38
145 N 3.5260.10 1.09
146 P 3.5360.10 1.25
A2 0.73 (0.67–0.79) 151 N 3.3960.30 0.93
154 P 2.7860.13 0.88
157 A 2.9460.15 0.95
158 T 3.3260.39 0.66
172 P 3.5360.16 0.95
176 V 3.5360.16 0.94
177 F 3.5360.16 1.10
70 S 4.7860.65 0.66
86 N 4.7760.67 0.63
100 E 4.7560.72 0.39
105 P 4.7660.69 0.63
B1 0.50 (0.49–0.51) 109 P 4.7760.66 0.77
111 G 4.7560.73 0.49
114 Y 4.7460.75 0.46
116 G 4.7860.64 0.68
136 P 4.6760.90 0.46
84 D 5.8160.64 0.60
85 P 5.8260.63 0.83
93 Q 5.8260.63 0.64
105 L 5.6161.12 0.54
109 L 5.8260.63 0.86
B2 0.93 (0.92–0.94) 111 D 5.8260.63 1.10
114 H 5.6061.16 0.30
119 P 5.7560.84 0.51
Table 2. Cont.
SubtypesMean dN/dS (CI
a) Positive selection site data
Position AA dN/dS ± S.E.
b Entropy
121 P 5.8260.63 0.76
125 V 5.5861.16 0.72
140 T 5.8260.63 0.79
aCI, 95% confidence interval,
bS.E. Standard error.
doi:10.1371/journal.pone.0034544.t002
Table 3. Selection analysis of the G genes of hMPV_A2
sublineages.
Sublineages
Mean
dN/dS
(CI
a) Positive selection site data
Position AA dN/dS ± S.E.
b Entropy
110 V 5.14660.822 0.21
145 N 5.12060.875 0.92
146 P 5.14660.822 0.78
A2a 0.68 (0.58–0.78) 151 N 5.14660.823 0.82
162 S 5.12860.859 0.67
172 P 5.02161.048 0.62
176 V 5.14660.822 0.66
177 F 5.04760.997 0.48
93 L 3.39960.302 0.78
102 P 3.39960.303 0.92
105 N 3.39960.302 0.92
106 S 3.39860.306 0.91
110 V 3.39860.480 0.33
A2b 0.82 (0.70–0.94) 126 R 3.39260.328 0.43
129 S 3.39960.302 0.57
145 K 3.39960.302 1.06
146 S 3.39960.302 1.10
151 R 3.28960.578 0.72
166 T 3.38560.353 0.74
aCI, 95% confidence interval.
bS.E. Standard error.
doi:10.1371/journal.pone.0034544.t003
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the population dynamics of the hMPV subtypes.
The analysis of relative genetic diversity level of hMPV subtypes
showed that hMPV_A2 was the highest after 2002 with a value
higher than 10, while those of other subtypes were lower than 10.
Meanwhile, hMPV_A2 exhibited a rising trend while other
subtypes remained steady after the only increase in relative
genetic diversity. These findings are correlated with the observa-
tion that hMPV_A2 has been the predominant subtype since
2002.
The first increase of the hMPV_A2 prevalence occurred
through an increase in the relative genetic diversity of hMPV_A2a
around 1997 (Figure 3B); the last two increases of the hMPV_A2
prevalence can be attributed to an increase in the relative genetic
diversity of hMPV_A2b. Although the relative genetic diversity of
hMPV_A2b has continued to rise since 2001, with a value higher
than 10, the relative genetic diversity of hMPV_A2a has remained
steady since 2001 with a value lower than 10. These findings
further support the fact that hMPV_A2b has been the predom-
inant sublineage of hMPV_A2.
Natural selection and adaptation of G protein
To investigate the extent of selection pressure on the G gene of
the hMPV subtypes and hMPV_A2 sublineages, the mean dN/dS
values among branches of the hMPV subtypes were estimated
using the M2a codon substitution model in the PAML version 4
[31]. Maximum-likelihood analysis showed that the evolution of
hMPV was driven mainly by the signal of purifying selection with
estimated values of mean dN/dS ranging from 0.49 to 0.94 for all
hMPV subtypes except hMPV_A1. For hMPV A1, the mean dN/
dS was 1.25, indicating a signal of positive selection (Table 2).
Although hMPV_A2 has atypically prevalent for an extended time
period, the mean dN/dS value of hMPV_A2 was the second
lowest among hMPV subtypes. The stronger negative selection
signal of hMPV_A2 is not surprising, as selection pressure on
individual sites may be the key determinant in the survival of
hMPV_A2.
Because individual site mutations may play a role in the atypical
prevalence of hMPV_A2, the positive selection sites of the hMPV
subtypes were estimated using a similar codon substitution model
(Table 2). We identified 14, 16, 9, and 11 positive selection sites for
hMPV_A1, A2, B1, and B2, respectively. Similar values of dN/dS
for positive selection sites within subtypes were observed.
Moreover, sites of hMPV_A1 had the highest dN/dS values and
sites of hMPV_A2 had the lowest values among hMPV subtypes.
It seems that the largest number of positive selection sites in
hMPV_A2 contribute to the atypical prevalence. An additional
entropy analysis on amino acids was also taken into account to
gain more supports [32,35]. Entropy analysis [32] identified 1, 3,
0, and 1 positive selection amino acids for hMPV_A1, A2, B1, and
B2, respectively, when the threshold of entropy was set to 1 [35].
Our findings show that because the G sequence of hMPV_A2 had
more positive selection sites than those of the other subtypes,
antigenic drift resulted in the increased hMPV_2 epidemic
[36,37]. Moreover, the positive selection sites of hMPV_A2a
and A2b were inferred independently at the codon and amino acid
levels. Although hMPV_A2a had a higher mean dN/dS value at
the codon level than hMPV_A2b, hMPV_A2b had more sites with
higher entropy at the amino acid level than hMPV_A2a (Table 3).
hMPV_A2b had 5 positive selection sites at the amino acid level,
whereas hMPV_A2a had 1, suggesting increased severity of the
hMPV_A2b epidemic [37].
To trace the positive selection sites in the G gene of hMPV
subtypes chronologically, ancestral sequence reconstructions
Figure 4. Molecular clock phylogeny of hMPV_A2. The phylogeny was reconstructed using hMPV G sequences longitudinally sampled
between 1981 and 2009. Branch lengths are expressed in unit of time.
doi:10.1371/journal.pone.0034544.g004
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temporal evolution routes of positive selection sites in hMPV_A2a
and A2b were drawn on the MCC tree of hMPV_A2 (Figure 4).
At least four types of mutation were identified at the positive
selection codon sites of hMPV_A2b (Figure 4).There was four
reverse changes at positions 93 (H-L-H), 102 (P-L-P), 129 (S-F-S),
and 151(K-R-K); a successive change at position 145 (K-N-T
between two successive nodes in 1998/2000); two multi-direction
changes at positions 105 and 146 (N105K/Y and P146R/S); and
two multi-time point changes at positions 146 (P146S in 2002/
2003) and 151 (K151R in 2000/2001). However, only two multi-
time point changes were observed in hMPV_A2a (P146L in 1992/
2001 and L172P in 1995/1997). The mutation hotspots and the
diverse mutation types identified for hMPV_A2b suggest that it
has been under high selection pressure, consistent with the
atypically long-lasting epidemic of hMPV_A2. Mutation hotspots
in the temporal evolution routes of other hMPV subtypes were
similarly assessed (see Figure S1). Only two multi-time point
changes in hMPV_A1 and a successive change in hMPV_B1 were
observed. For hMPV_B2, two successive changes and two multi-
time point changes were found.
Phylogeography analysis
To determine the mechanism behind the rise of hMPV_A2b in
recent years, the spatial diffusion of the time-scaled genealogy of
hMPV_A2b was traced using a recently developed BSSVS
approach (Figure 5). By June 2002, hMPV_A2b had emerged in
the Netherlands and spread to Canada, Japan, and Beijing, China.
By June 2006, the spread routes from the Netherlands and Japan
had joined in India, and another route from Canada to USA had
emerged. By June 2008, hMPV_A2b had spread from USA to
Beijing, China and joined the route from the Netherlands.
Coincidently, hMPV_A2b sequences retrieved from GenBank
boosted from India in 2006 and Beijing, China in 2008 (Figure 6,
Table S3). The consistency between the phylogeographic data and
the atypical epidemic of hMPV_A2 show that viral transmission
plays an important role in the growth of the virus-infected
population, which further explains the atypical epidemic of
hMPV_A2b in recent years.
Figure 5. Temporal dynamics of spatial hMPV A2b diffusion.
Snapshots of the dispersal pattern for June of 2002, 2006, and 2008 are
shown. The location-annotated MCC tree based on the maximum clade
credibility tree of hMPV_A2b were converted to KML files for visualizing
in Google Earth (http: earth.google.com) (35). Lines between locations
represent branches in the MCC tree along which the relevant location
transition occurred. The time at the left bottom of each snapshot
informs the relative age of the transitions of hMPV_A2b.
doi:10.1371/journal.pone.0034544.g005
Figure 6. Number of hMPV_A2b sequences deposited to
GenBank from India and Beijing, China between 2004 and
2009. G and F gene sequences of hMPV_A2b collected from India and
Beijing, China between 2004 and 2009 were retrieved from GenBank. All
the G and F sequences were obtained from different isolates to avoid
repetitive statistics. Genotyping of these sequences was based on the
relative reports and confirmed by Neighbor-joining based phylogeny
reconstruction as described previously (55).
doi:10.1371/journal.pone.0034544.g006
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Our analysis of the global prevalence of hMPV subtypes shows
a long-lasting epidemic of hMPV_A2 that is atypical in
comparison with those of the other hMPV subtypes. To study
the mechanism behind this hMPV_A2 prevalence, we assessed
phylodynamics, natural selection and adaptation, and phylogeog-
raphy of the hMPV subtypes and the hMPV_A2 sublineages. Our
evolutionary dynamics data are consistent with the atypical
epidemic pattern of hMPV_A2 in recent years, providing a
molecular evolutionary explanation for the atypical hMPV_A2
epidemic.
The substitution rates of hMPV G genes in this study were
estimated to a range of 4.42–8.54610
23 substitutions/site/year,
which is similar to those reported by Padhi et al [10], but higher
than those of de Graaf et al [38]. We found that hMPV_A2 had
the second highest substitution rate after hMPV_B1. However,
genetic distance estimation revealed that the overall mean distance
of hMPV_A2 is at least two-fold higher than that of all other
subtypes. Because hMPV_A2 has the largest overall mean distance
and the second-highest substitution rate in G genes, it may have
evolved fastest toward heterogeneity, explaining its time serial
trend of the effective population size as well as its atypical
epidemic.
The Bayesian skyline plots show a general upward trend in the
relative genetic diversity of hMPV_A2, which is higher than that
of the other hMPV subtypes. This is consistent with its atypical
prevalence pattern, as relative genetic diversity level is one
determinant of viral survival [39,40]. Other hMPV subtypes show
a steady level of relative genetic diversity after 2005, consistent
with their lower prevalence during the same time period.
Moreover, most fluctuations in relative genetic diversity presented
here largely agree with the global prevalence of all hMPV
subtypes, except hMPV_B2, demonstrating that relative genetic
diversity can reveal viral features of epidemic dynamics [39].
Insufficient screening of hMPV from clinical specimens might
account for the inconsistency between epidemic dynamics and the
increased prevalence of hMPV_B2 between 1995 and 1997, as
hMPV was not recognized as a human pathogen until 2001.
Overall, our data suggest that the pattern of relative genetic
diversity matches the corresponding epidemics of hMPV,
indicating that the relative dynamics of genetic diversity can be
used to explain the patterns of past epidemics of hMPV.
One indication of purifying selection could be seen in mean
dN/dS values under 1, which were observed for each hMPV
subtype, except hMPV_A1. hMPV_A1 had a mean dN/dS value
of 1.25. This strong signal of positive selection in hMPV _A1
seems to reflect an intense fluctuation in its history of genetic
diversity. Although hMPV_A2 had the second lowest mean dN/
dS value, it had the largest number of positive selection sites.
These positive selection sites contained various mutation hotspots
in the temporal evolution routes of hMPV_A2b. Fewer positive
selection sites were observed in hMPV_A2a than in hMPV_A2b,
and fewer mutation hotspots were found in the temporal evolution
routes of hMPV_A1, B1, and B2 than in hMPV_A2. These
findings show that hMPV_A2 has undergone higher selection
pressure in the temporal evolution routes than the other subtypes,
consistent with the atypical epidemic of hMPV_A2. Because the
epidemic and evolutionary dynamics of hMPV_A2b are similar to
that of hMPV_A2, hMPV_A2b may account for the atypical
epidemic of hMPV_A2.
We also used phylogeography analysis to investigate the
epidemiological history and the diffusion routes of the epidemic
hMPV virus. Our Bayesian phylogeography analysis revealed two
fusions in the diffusion routes of hMPV_A2b. Because sequences
from identical isolates were excluded, our findings suggest that the
viral transmission from different regions enhanced the viral
capacity against host immunity and thereby intensified the
hMPV_A2b epidemic. A possible reason is that host immunity
cannot effectively fight against the novel strain of antigenic
divergent hMPV_A2b, causing a higher viral prevalence when the
novel hMPV_A2b strain was introduced to a specific population.
These findings confirm that epidemic history, along with spatial-
temporal dynamics of gene flow and phylogeography analysis need
to be considered in the planning of prevention strategies, as has
previously been suggested [41,42]
In summary, the evolutionary dynamics of hMPV subtypes
determined in this study provide insight into the epidemic and
variation of hMPV in recent years. These data can contribute to
the diagnosis, surveillance, and control of hMPV as well as for
future vaccine development.
Supporting Information
Figure S1 Molecular clock phylogenies of hMPV sub-
types. The phylogenies were reconstructed longitudinally using G
gene sequences of hMPV subtypes with branch lengths expressed
in unit of time.
(TIF)
Table S1 Sequences information of the hMPV G gene
enrolled in this study.
(DOC)
Table S2 Global epidemiology of hMPV subtypes
during 1999 and 2009.
(DOC)
Table S3 G and F sequences of hMPV_A2b submitted to
GenBank from India and Beijing, China.
(DOC)
Acknowledgments
We thank Dr. Xinjian Zhang from US CDC for the critical discussion and
helpful suggestions. We thank the clinicians of the Beijing Children’s
Hospital and the Peking Union Medical College Hospital for collecting the
clinical specimens.
Author Contributions
Conceived and designed the experiments: JL GP GV JW. Performed the
experiments: JL LR LG ZX. Analyzed the data: JL LR LG ZX GV JW.
Contributed reagents/materials/analysis tools: JL JW. Wrote the paper: JL
JW. Contributed to the scientific discussions: JL LR ZX JW.
References
1. van den Hoogen BG, de Jong JC, Groen J, Kuiken T, de Groot R, et al. (2001)
A newly discovered human pneumovirus isolated from young children with
respiratory tract disease. Nat Med 7: 719–724.
2. Agapov E, Sumino KC, Gaudreault-Keener M, Storch GA, Holtzman MJ
(2006) Genetic variability of human metapneumovirus infection: evidence of a
shift in viral genotype without a change in illness. J Infect Dis 193: 396–403.
3. El Sayed Zaki M, Raafat D, El-Metaal AA, Ismail M (2009) Study of human
metapneumovirus-associated lower respiratory tract infections in Egyptian
adults. Microbiol Immunol 53: 603–608.
4. Bastien N, Normand S, Taylor T, Ward D, Peret TC, et al. (2003) Sequence
analysis of the N, P, M and F genes of Canadian human metapneumovirus
strains. Virus Res 93: 51–62.
Evolutionary Dynamics of hMPV Subtypes
PLoS ONE | www.plosone.org 8 March 2012 | Volume 7 | Issue 3 | e345445. Biacchesi S, Pham QN, Skiadopoulos MH, Murphy BR, Collins PL, et al. (2005)
Infection of nonhuman primates with recombinant human metapneumovirus
lacking the SH, G, or M2-2 protein categorizes each as a nonessential accessory
protein and identifies vaccine candidates. J Virol 79: 12608–12613.
6. Biacchesi S, Skiadopoulos MH, Yang L, Lamirande EW, Tran KC, et al. (2004)
Recombinant human Metapneumovirus lacking the small hydrophobic SH
and/or attachment G glycoprotein: deletion of G yields a promising vaccine
candidate. J Virol 78: 12877–12887.
7. Kahn JS (2006) Epidemiology of human metapneumovirus. Clin Microbiol Rev
19: 546–557.
8. Peret TC, Abed Y, Anderson LJ, Erdman DD, Boivin G (2004) Sequence
polymorphism of the predicted human metapneumovirus G glycoprotein. J Gen
Virol 85: 679–686.
9. Ishiguro N, Ebihara T, Endo R, Ma X, Kikuta H, et al. (2004) High genetic
diversity of the attachment (G) protein of human metapneumovirus. J Clin
Microbiol 42: 3406–3414.
10. Padhi A, Verghese B (2008) Positive natural selection in the evolution of human
metapneumovirus attachment glycoprotein. Virus Res 131: 121–131.
11. Agapov E, Sumino KC, Gaudreault-Keener M, Storch GA, Holtzman MJ
(2006) Genetic variability of human metapneumovirus infection: evidence of a
shift in viral genotype without a change in illness. J Infect Dis 193: 396–403.
12. Huck B, Scharf G, Neumann-Haefelin D, Puppe W, Weigl J, et al. (2006) Novel
human metapneumovirus sublineage. Emerg Infect Dis 12: 147–150.
13. Peret TC, Hall CB, Hammond GW, Piedra PA, Storch GA, et al. (2000)
Circulation patterns of group A and B human respiratory syncytial virus
genotypes in 5 communities in North America. J Infect Dis 181: 1891–1896.
14. Peret TC, Hall CB, Schnabel KC, Golub JA, Anderson LJ (1998) Circulation
patterns of genetically distinct group A and B strains of human respiratory
syncytial virus in a community. J Gen Virol 79(Pt 9): 2221–2229.
15. Chung JY, Han TH, Kim SW, Hwang ES (2008) Genotype variability of human
metapneumovirus, South Korea. J Med Virol 80: 902–905.
16. Ludewick HP, Abed Y, van Niekerk N, Boivin G, Klugman KP, et al. (2005)
Human metapneumovirus genetic variability, South Africa. Emerg Infect Dis
11: 1074–1078.
17. Mackay IM, Bialasiewicz S, Jacob KC, McQueen E, Arden KE, et al. (2006)
Genetic diversity of human metapneumovirus over 4 consecutive years in
Australia. J Infect Dis 193: 1630–1633.
18. Oliveira DB, Durigon EL, Carvalho AC, Leal AL, Souza TS, et al. (2009)
Epidemiology and genetic variability of human metapneumovirus during a 4-
year-long study in Southeastern Brazil. J Med Virol 81: 915–921.
19. Sloots TP, Mackay IM, Bialasiewicz S, Jacob KC, McQueen E, et al. (2006)
Human metapneumovirus, Australia, 2001–2004. Emerg Infect Dis 12:
1263–1266.
20. Caracciolo S, Minini C, Colombrita D, Rossi D, Miglietti N, et al. (2008)
Human metapneumovirus infection in young children hospitalized with acute
respiratory tract disease: virologic and clinical features. Pediatr Infect Dis J 27:
406–412.
21. Gerna G, Campanini G, Rovida F, Sarasini A, Lilleri D, et al. (2005) Changing
circulation rate of human metapneumovirus strains and types among
hospitalized pediatric patients during three consecutive winter-spring seasons.
Brief report. Arch Virol 150: 2365–2375.
22. Noyola DE, Alpuche-Solis AG, Herrera-Diaz A, Soria-Guerra RE, Sanchez-
Alvarado J, et al. (2005) Human metapneumovirus infections in Mexico:
epidemiological and clinical characteristics. J Med Microbiol 54: 969–974.
23. Sarasini A, Percivalle E, Rovida F, Campanini G, Genini E, et al. (2006)
Detection and pathogenicity of human metapneumovirus respiratory infection in
pediatric Italian patients during a winter–spring season. J Clin Virol 35: 59–68.
24. Ren L, Gonzalez R, Wang Z, Xiang Z, Wang Y, et al. (2009) Prevalence of
human respiratory viruses in adults with acute respiratory tract infections in
Beijing, 2005–2007. Clin Microbiol Infect 15: 1146–1153.
25. Ren L, Gonzalez R, Xie Z, Zhang J, Liu C, et al. (2008) WU and KI
polyomavirus present in the respiratory tract of children, but not in
immunocompetent adults. J Clin Virol 43: 330–333.
26. Ahumada-Ruiz S, Casado C, Toala-Gonzalez I, Flores-Figueroa D, Rodriguez-
French A, et al. (2008) High divergence within the major HIV type 1 subtype B
epidemic in Panama. AIDS Res Hum Retroviruses 24: 1461–1466.
27. Tamura K, Dudley J, Nei M, Kumar S (2007) MEGA4: Molecular Evolutionary
Genetics Analysis (MEGA) software version 4.0. Mol Biol Evol 24: 1596–1599.
28. Wilgenbusch JC, Swofford D (2003) Inferring evolutionary trees with PAUP*.
Curr Protoc Bioinformatics Chapter 6: Unit 64.
29. Drummond AJ, Rambaut A (2007) BEAST: Bayesian evolutionary analysis by
sampling trees. BMC Evol Biol 7: 214.
30. Posada D, Crandall KA (1998) MODELTEST: testing the model of DNA
substitution. Bioinformatics 14: 817–818.
31. Yang Z (2007) PAML 4: phylogenetic analysis by maximum likelihood. Mol Biol
Evol 24: 1586–1591.
32. Dolz R, Pujols J, Ordonez G, Porta R, Majo N (2008) Molecular epidemiology
and evolution of avian infectious bronchitis virus in Spain over a fourteen-year
period. Virology 374: 50–59.
33. Pond SL, Frost SD, Muse SV (2005) HyPhy: hypothesis testing using
phylogenies. Bioinformatics 21: 676–679.
34. Lemey P, Rambaut A, Drummond AJ, Suchard MA (2009) Bayesian
phylogeography finds its roots. PLoS Comput Biol 5: e1000520.
35. Pan K, Deem MW (2011) Quantifying selection and diversity in viruses by
entropy methods, with application to the haemagglutinin of H3N2 influenza.
J R Soc Interface 8(64): 1644–1653.
36. Liao YC, Lee MS, Ko CY, Hsiung CA (2008) Bioinformatics models for
predicting antigenic variants of influenza A/H3N2 virus. Bioinformatics 24:
505–512.
37. Wolf YI, Nikolskaya A, Cherry JL, Viboud C, Koonin E, et al. (2010) Projection
of seasonal influenza severity from sequence and serological data. PLoS Curr 2:
RRN1200.
38. de Graaf M, Osterhaus AD, Fouchier RA, Holmes EC (2008) Evolutionary
dynamics of human and avian metapneumoviruses. J Gen Virol 89: 2933–2942.
39. Holmes EC, Grenfell BT (2009) Discovering the phylodynamics of RNA viruses.
PLoS Comput Biol 5: e1000505.
40. Tee KK, Lam TT, Chan YF, Bible JM, Kamarulzaman A, et al. (2010)
Evolutionary genetics of human enterovirus 71: origin, population dynamics,
natural selection, and seasonal periodicity of the VP1 gene. J Virol 84:
3339–3350.
41. Pybus OG, Rambaut A (2009) Evolutionary analysis of the dynamics of viral
infectious disease. Nat Rev Genet 10: 540–550.
42. Zehender G, Ebranati E, Bernini F, Presti AL, Rezza G, et al. (2011)
Phylogeography and epidemiological history of West Nile virus genotype 1a in
Europe and the Mediterranean basin. Infect Genet Evol 11(3): 646–653.
Evolutionary Dynamics of hMPV Subtypes
PLoS ONE | www.plosone.org 9 March 2012 | Volume 7 | Issue 3 | e34544